| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | -0.068 | 0.03 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.03 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.12 | 0.04 |
| mRNA | methylstat | CTRPv2 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |